EP Wealth Advisors LLC Makes New $295,000 Investment in Haleon plc (NYSE:HLN)

EP Wealth Advisors LLC bought a new position in Haleon plc (NYSE:HLN) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 5,000 shares of the company’s stock, valued at approximately $295,000.

Other institutional investors have also recently modified their holdings of the company. City State Bank bought a new position in shares of Haleon during the 1st quarter valued at about $25,000. CoreFirst Bank & Trust bought a new position in shares of Haleon during the 4th quarter valued at about $26,000. Ahrens Investment Partners LLC bought a new position in shares of Haleon during the 1st quarter valued at about $27,000. GW&K Investment Management LLC increased its position in shares of Haleon by 308.4% during the 1st quarter. GW&K Investment Management LLC now owns 3,529 shares of the company’s stock valued at $29,000 after purchasing an additional 2,665 shares during the last quarter. Finally, Resurgent Financial Advisors LLC bought a new position in shares of Haleon during the 4th quarter valued at about $29,000. 6.67% of the stock is currently owned by institutional investors.

Haleon Stock Up 0.2 %

HLN opened at $8.27 on Monday. The stock’s 50 day simple moving average is $8.37 and its 200 day simple moving average is $8.37. The company has a debt-to-equity ratio of 0.53, a quick ratio of 0.54 and a current ratio of 0.84. Haleon plc has a 1 year low of $5.79 and a 1 year high of $9.05.

Haleon (NYSE:HLN) last posted its quarterly earnings results on Wednesday, August 2nd. The company reported $0.08 earnings per share (EPS) for the quarter. The company had revenue of $3.44 billion for the quarter. As a group, sell-side analysts anticipate that Haleon plc will post 0.45 EPS for the current fiscal year.

Haleon Cuts Dividend

The firm also recently disclosed a — dividend, which will be paid on Thursday, October 5th. Shareholders of record on Friday, August 25th will be issued a $0.046 dividend. This represents a yield of 1.3%. The ex-dividend date is Thursday, August 24th.

Wall Street Analysts Forecast Growth

Several brokerages have recently commented on HLN. Stifel Nicolaus began coverage on Haleon in a research report on Wednesday, May 24th. They set a “hold” rating on the stock. Investec upgraded Haleon from a “sell” rating to a “hold” rating in a research report on Tuesday, August 8th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $364.00.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, minerals, and supplements.